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Systemic capillary leak syndrome (SCLS) is a rare but
devastating clinical condition first described by Clarkson
et al. [1] in 1960. The last review of this syndrome in 2006
analyzed 75 cases, but only 50 had complete clinical data
[2]. Clinically, the syndrome is characterized by hypoten-
sion, hypoalbuminemia and hemoconcentration, and is
caused by the shift of fluid and protein from the intravas-
cular space to the interstitial space as a result of capillary
hyperpermeability. The purpose of this report is to enhance
awareness of this syndrome that may be frequently un-
derdiagnosed because of its rarity and wide range of
presentation.
In November 2004, the patient, a 46-year-old man in
prior good health, was admitted acutely to the hospital for
severe hypotension (systemic arterial pressure 70/
50 mmHg, heart rate 110 beats per min) generalized
edema, cyanosis and altered consciousness. The prior day,
he had experienced fever, abdominal pain, dizziness and
forearm swelling. Selected laboratory data revealed: red
blood cell count 6.17 9 106/ll, hemoglobin 18.4 g/dl,
hematocrit 53%, leukocyte cell count 35.00 9 103/ll,
blood urea nitrogen 70 mg/dl, creatinine level 3 mg/dl,
total protein 4.2 g/dl, albumin 2.2 g/dl; urinalysis for pro-
teinuria was negative. The body temperature was 39C, the
D-dimer was 847 ng/ml. During the acute phase, ampicillin
plus sulbactam, steroids (40 mg methylprednisolone each
day), albumin and intravenous fluid therapy (10 L of fluid
during 72 h) were administered. After 24 h there was an
improvement of symptoms with polyuria and edema reso-
lution. Common causes of generalized edema accompanied
by hypoproteinemia were excluded such as the nephrotic
syndrome, liver dysfunction, congestive heart failure and
gastrointestinal protein losing enteropathy. A chest radio-
graph revealed a slight pleural effusion without any
abnormal shadows of the lungs. The pericardial effusion
was demonstrable on an echocardiogram. Ascites was also
present. During the hospitalization, tests for antinuclear
antibodies and antibodies to DNA were negative. Adrenal
and thyroid hormones were at the upper level of the normal
ranges. A small amount of monoclonal IgG-k protein in the
serum was evident. A bone morrow aspiration was per-
formed and was normal. After 10 days, the patient was
discharged with a diagnosis of viral polyserositis with
acute glomerulonephritis, without further therapy. In Jan-
uary 2005, the patient suffered a second episode of hypo-
volemic shock (systemic arterial pressure 60/30 mmHg),
with tachycardia (heart rate 120 beats per min), hemo-
concentration (red blood cell count 8.22 9 106/ll, total
leukocyte cell count 49.00 9 103/ll, hematocrit 62.3%),
oliguria, peripheral vasoconstriction and derangement in
hemostasis (aPTT 57 s, INR 5.88, platelets count 70,000/
mm3 and fibrinogen 114 mg/dl). Further laboratory values
were: albumin 1.5 g/dl, total protein 2.9 g/dl, creatinine
3.2 mg/dl, blood urea 102 mg/dl. Arterial blood gas anal-
ysis showed the following values: pH 7.28, paO2
65 mmHg, paCO2 32 mmHg, HCO3
- 15 mEq/l. During
48 h an aggressive fluid support was given in the form of
plasma plus plasma expanders, normal saline infusion
(glucose 5%), associated with methylprednisolone, antibi-
otics (teicoplanine and ceftazidime). A clinical improve-
ment was seen after 24–36 h. The diagnosis at discharge
was hypovolemic shock with coagulopathy and renal
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insufficiency. No therapy to prevent episodes was sug-
gested. During the following 2 years the patient experi-
enced about eight episodes characterized by forearm
swelling, dizziness, fatigue and mild hypotension; intra-
venous hydrocortisone was used with slight recovery from
the symptoms.
Finally in December 2007, the patient was admitted to
our Department of Internal Medicine. All laboratory and
diagnostic tests were negative except for the presence of
monoclonal IgGk protein. On the bases of the clinical
history, we made the diagnosis of idiopathic SCLS.
Therefore, prophylaxis with b2 agonists (clembuterol
0.02 mg twice daily) and theophylline (200 mg twice
daily) was started. No acute episode has been documented
or prodromal symptoms requiring intravenous hydrocorti-
sone have been reported during a 12-month follow-up.
The clinical presentation of SCLS is currently divided
into two stages: the initial capillary leak phase and the
recruitment phase. Prodromal symptoms include myal-
gias, fatigue, abdominal pain, nausea, and in some cases,
polydipsia and dizziness. The capillary leak phase may
last from 1 to 4 days, and is a phase of acute hypo-
volemia with capillary high-permeability and marked
extravasation of intravascular fluids and macromolecules.
Laboratory findings reveal hemoconcentration, leukocy-
tosis, increase in IgM, decrease in albumin and decrease
in IgG. At peak of an SCLS episode, the clinical features
include generalized edema, interstitial edema, ascites,
pleural and pericardial effusions. A compartment syn-
drome caused by massive swelling of muscular com-
partments sometimes requiring fasciotomy, is an
uncommon complication as well as is rhabdomyolysis.
Renal failure can result from acute tubular necrosis due
to hypotensive shock and rhabdomyolysis.
The recruitment phase follows the capillary leak phase
and involves the normalization of the vascular leak. During
this phase, the interstitial fluid, native and supplemental,
returns to the intravascular space, and may result in intra-
vascular fluid overload. Although the patient’s kidneys
may function normally, pulmonary edema may result. In
between episodes, patients are asymptomatic except for
monoclonal gammopathy (70% of patients) without any
evidence of multiple myeloma or amyloidosis. In some
cases, a progression to multiple myeloma has been
described [3].
The therapy of the acute phase consists of intravenous
fluids (crystalloids and colloids), with most episodes
resolving with this therapy [4]. Additionally, the aggressive
fluid infusion in the leaking phase can result in pulmonary
edema during recovery. In some patients, inotropes,
mechanical ventilation and ultradiafiltration have been
utilized. Intravenous steroid therapy may have a role in the
acute leaking phase, where cytokine-mediated endothelial
damage is prominent.
Many drugs have been tried to prevent future episodes.
Terbutaline and theophylline reduce the increment of the
capillary permeability induced by bradykinin by producing
an increase of cyclic adenosine monophosphate [5]. Since
1981 a combination of aminophylline or theophylline plus
terbutaline has been used at the Mayo Clinic Center to treat
the recurrence of SCLS. With this regimen, a number of
episodes of SCLS are completely prevented in some
patients, and decreased in incidence and severity in others.
Other agents used are intravenous immunoglobulins,
prednisone, verapamil, leukotrienes modifiers and plas-
mapheresis. Although morbidity and mortality rates are
still high, the prognosis seems improved in part due to
careful monitoring of fluid volume and aggressive inten-
sive care during attacks as well as treatment during the
chronic phase.
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